Matt Kaplan

Matt Kaplan

Direktor/Vorstandsmitglied bei NUVECTIS PHARMA, INC.

Vermögen: 567 055 $ am 31.05.2024

56 Jahre
Finance
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Matt Kaplan

EinheitArt der EinheitIndustrie
63
Operating Division Investment Banks/Brokers 63
Public Company Pharmaceuticals: Major 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Matt Kaplan

UnternehmenSektorVerknüpfte PersonenHauptposition
Investment Managers

Robert Hazlett

Eduardo Seda

Christopher Nolan

Geoffrey O'Brien

Mickey M. Schleien

Corporate Officer/Principal

Analyst-Equity

Analyst-Equity

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Kevin DeGeeter

Christopher Nolan

Xue Dong Tian

Vinod Srinivasaraghavan

Aydin Huseynov

Analyst-Equity

Analyst-Equity

Analyst-Equity

Analyst-Equity

Analyst-Equity

KERYX BIOPHARMACEUTICALS Pharmaceuticals: Major

Ronald Bentsur

Kenneth Hoberman

James Oliviero

Enrique Poradosu

Shay Shemesh

Chief Executive Officer

Corporate Officer/Principal

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Robert Hazlett

Robert LeBoyer

Michael Higgins

Rui Galvao

Maria Barbera

Analyst-Equity

Analyst-Equity

Analyst-Equity

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Paul Fremont

Bradley Ball

Michael C. Schmitz

Arren Cyganovich

Analyst-Equity

Analyst-Equity

Analyst-Equity

Analyst-Equity

Regional Banks

Peter Blum

Mark Klein

Juan F. Sanchez

David Rosenberg

Chief Executive Officer

Chairman

Corporate Officer/Principal

Chief Executive Officer

The Trustees of Columbia University in The City of New York College/University

Robert Hazlett

Eduardo Seda

Juan F. Sanchez

Dick Bove

Masters Business Admin

Masters Business Admin

Graduate Degree

Undergraduate Degree

STEMLINE THERAPEUTICS, INC. Pharmaceuticals: Major

Ronald Bentsur

Kenneth Hoberman

Enrique Poradosu

Shay Shemesh

Director/Board Member

Chief Operating Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Paul Fremont

Scott Graham

Aaron Schwartz

Brandon Travis

Analyst-Equity

Analyst-Equity

Analyst-Equity

Analyst-Equity

New York University College/University

Paul Fremont

James S. Rosenthal

Xue Dong Tian

Masters Business Admin

Masters Business Admin

Masters Business Admin

College/University

Scott Graham

John L. Bligh

John J. Massocca

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Investment Banks/Brokers

Paul Fremont

Robert LeBoyer

Noel Parks

Analyst-Equity

Analyst-Equity

Corporate Officer/Principal

Investment Banks/Brokers

Eduardo Seda

Glenn G. Mattson

Vinod Srinivasaraghavan

Analyst-Equity

Analyst-Equity

Corporate Officer/Principal

Investment Banks/Brokers

Eduardo Seda

David Walrod

Jonathan R Montanus

Analyst-Equity

Analyst-Equity

Trading-Equity

Investment Banks/Brokers

Kevin DeGeeter

Noel Parks

Edward Marks

Analyst-Equity

Analyst-Equity

Analyst-Equity

The Hebrew University of Jerusalem College/University

Ronald Bentsur

Daniel L. Amir

Enrique Poradosu

Undergraduate Degree

Graduate Degree

Doctorate Degree

University of Wisconsin College/University

Peter Blum

Michael Higgins

David Rosenberg

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Banks/Brokers

Michael C. Schmitz

Scott Graham

Richard Verdi

Analyst-Equity

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Robert Hazlett

Scott Graham

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Paul Fremont

Vinod Srinivasaraghavan

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

William B. Acheson

Aydin Huseynov

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Kevin DeGeeter

Adolfo R. Rueda

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Bradley Ball

Arren Cyganovich

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Ed Groshans

Vinod Srinivasaraghavan

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Robert LeBoyer

Ahu Demir

Analyst-Equity

Analyst-Equity

Boston University College/University

Ed Groshans

Kenneth Hoberman

Masters Business Admin

Undergraduate Degree

Bar-Ilan University College/University

Uri Ben-Or

Shay Shemesh

Masters Business Admin

Graduate Degree

Investment Banks/Brokers

Robert Hazlett

James Colby

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Jeff Langbaum

Vinod Srinivasaraghavan

Analyst-Equity

Analyst-Equity

Tulane University (Louisiana) College/University

Scott Graham

Robert LeBoyer

Undergraduate Degree

Undergraduate Degree

Investment Banks/Brokers

Scott Graham

James Allen Villard

Analyst-Equity

Corporate Officer/Principal

Investment Managers

Aaron Schwartz

Daniel L. Amir

Analyst-Equity

Corporate Officer/Principal

Investment Banks/Brokers

Robert LeBoyer

Christopher Nolan

Analyst-Equity

Analyst-Equity

Columbia Business School College/University

Robert LeBoyer

Christopher Nolan

Masters Business Admin

Masters Business Admin

Investment Banks/Brokers

Casey Alexander

Ed Groshans

Analyst-Equity

Analyst-Fixed Income

Investment Banks/Brokers

Noel Parks

David Walrod

Analyst-Equity

Corporate Officer/Principal

Investment Banks/Brokers

Robert LeBoyer

Christopher S. James

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Noel Parks

Richard Verdi

Analyst-Equity

Analyst-Equity

University of Delaware College/University

Geoffrey O'Brien

Edward Marks

Undergraduate Degree

Doctorate Degree

Statistik

International

Vereinigte Staaten 49
Israel 3

Sektoral

Finance 39
Consumer Services 11
Health Technology 3

Operativ

Analyst-Equity 186
Corporate Officer/Principal 124
Undergraduate Degree 55
Director/Board Member 41
Director of Finance/CFO 39
  1. Börse
  2. Insiders
  3. Matt Kaplan
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT